Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sergey V, Borisevich"'
Autor:
Lyudmila F. Stovba, Aleksandr A. Petrov, Dеnis P. Belozerov, Oleg V. Chukhralia, Sergey A. Melnikov, Sergey V. Borisevich
Publikováno v:
Вестник войск РХБ защиты, Vol 8, Iss 3, Pp 232-242 (2024)
There is a danger that a natural smallpox virus may be reintroduced from the unknown spring or that a similar virus with the same pathogenic properties may appear or that somebody may create a synthetic copy of such a virus. That is why it is crucial
Externí odkaz:
https://doaj.org/article/83eda79ebcb14bee8b1b765c13d504e0
Autor:
Gennady G. Onishenko, Igor A. Kirillov, Sergey V. Borisevich, Tatiana E. Sizikova, Victor T. Krotkov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 101, Iss 3, Pp 399-411 (2024)
Discontinuation of vaccination after the completion of Smallpox global eradication program led to a sharp decrease in the level of collective immunity not only to smallpox but also to other orthopoxvirus infections. Over the past 10–15 years, the w
Externí odkaz:
https://doaj.org/article/5da2e8a4fcf9430183f3318fa3ab2f21
Publikováno v:
Вопросы вирусологии, Vol 69, Iss 3, Pp 203-218 (2024)
The basis for criteria of the taxonomic classification of DNA and RNA viruses based on data of the genomic sequencing are viewed in this review. The genomic sequences of viruses, which have genome represented by double-stranded DNA (orthopoxviruses a
Externí odkaz:
https://doaj.org/article/8bb3c096d39c4a2ebd2def59ac1c4a26
Autor:
Elena E. Popadyuk, Tatyana E. Sizikova, Aleksey L. Khmelev, Mikhail A. Timofeev, Vitaliy N. Lebedev, Sergey V. Borisevich
Publikováno v:
Вопросы вирусологии, Vol 69, Iss 2, Pp 119-126 (2024)
Introduction. When a new disease occurs, one of the most affordable remedies is drugs containing specific antibodies to this infectious agent. The use of such drugs is aimed at reducing the amount of the pathogen in the macroorganism and the associat
Externí odkaz:
https://doaj.org/article/1c680954c770486c94e6c439c6649d4e
Autor:
Anna V. Kovyrshina, Tatiana E. Sizikova, Vitaliy N. Lebedev, Sergey V. Borisevich, Inna V. Dolzhikova, Denis Yu. Logunov, Alexander L. Gintsburg
Publikováno v:
Вопросы вирусологии, Vol 68, Iss 5, Pp 372-384 (2023)
Relevance. Ebola virus disease (EVD) is an acute infectious disease with an extremely high case fatality rate reaching up to 90%. EVD has become widely known since 20142016, when outbreak in West Africa occurred and led to epidemic, which caused trav
Externí odkaz:
https://doaj.org/article/124f2f414d00433b840230a982b12f9a
Autor:
Marina M. Ziganshina, Nadezhda V. Shilova, Eugenia O. Khalturina, Natalya V. Dolgushina, Sergey V. Borisevich, Ekaterina L. Yarotskaya, Nicolai V. Bovin, Gennady T. Sukhikh
Publikováno v:
Viruses, Vol 15, Iss 7, p 1584 (2023)
Antibody-dependent enhancement (ADE) is a phenomenon where virus-specific antibodies paradoxically cause enhanced viral replication and/or excessive immune responses, leading to infection exacerbation, tissue damage, and multiple organ failure. ADE h
Externí odkaz:
https://doaj.org/article/1715c5572b5b4c80badc2c6a368d6a3c
Publikováno v:
Annals of the Russian academy of medical sciences. 77:172-180
The outbreak of a new coronavirus disease,COVID-19, started in December 2019 in China continues to be one of the most important realities of our time influencing all spheres of human activity March 11, 2022 marks two years since the WHO declared a pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0b6b631f6958a6dd755e1887713e312
https://doi.org/10.15690/vramn2013
https://doi.org/10.15690/vramn2013
Publikováno v:
Annals of the Russian academy of medical sciences. 76:652-660
The most effective means of combating the COVID-19 pandemic s the formation of herd immunity, with the formation of an immune population to infection. Vaccination rates are continuously increasing. In early February 2021, WHO announced that the numbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a748019dc04d55bdc7fa3691821df988
https://doi.org/10.15690/vramn1672
https://doi.org/10.15690/vramn1672
Autor:
Ilias B. Esmagambetov, Dmitriy V. Shcheblyakov, Daria A. Egorova, Olga L. Voronina, Artem A. Derkaev, Daria V. Voronina, Olga Popova, Ekaterina I. Ryabova, Dmitriy N. Shcherbinin, Ekaterina I. Aksenova, Andrey N. Semenov, Marina S. Kunda, Natalia N. Ryzhova, Olga V. Zubkova, Amir I. Tukhvatulin, Denis Yu. Logunov, Boris S. Naroditsky, Sergey V. Borisevich, Alexander L. Gintsburg
Publikováno v:
Acta Naturae
Ebola fever is an acute, highly contagious viral disease with a mortality rate that can reach 90%. There are currently no licensed therapeutic agents specific to Ebola in the world. Monoclonal antibodies (MAbs) with viral-neutralizing activity and hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2153c3a8f3ff59d5471c7a9d31774bd
https://doi.org/10.32607/actanaturae.11487
https://doi.org/10.32607/actanaturae.11487
Publikováno v:
Epidemiology and Infectious Diseases. 23:294-300
The some epidemiologic characteristics of etiologic agent of disease, possible main and intermediate reservoirs of agent in the nature, mechanism of agents transmission, modern methods of diagnostics and identification of agent, perspective trends of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05166094ca12ca5e58dd7f3ebf4e627b
https://doi.org/10.18821/1560-9529-2018-23-6-294-300
https://doi.org/10.18821/1560-9529-2018-23-6-294-300